SEC Form 4 · accession 0001127430-17-000051
INSMED Inc · INSM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eugene Jeffrey Sullivan
Officer — Chief Med. & Scientific Ofc.
Period of report
May 17, 2017
Accepted (ET)
May 19, 2017 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001104506
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $17.16 | May 17, 2017 | A | 33,300 | A | — | May 17, 2027 | Common Stock | 33,300 | 33,300 | D |
Explanation of responses
- F1Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.